Rare Disease Researcher, Teacher, Mentor, Associate Editor Organic Syntheses, #astrophotography | you can murmur all you like.
Notre Dame, IN
Joined February 2009
- Tweets4.8K
- Following1.1K
- Followers924
- Likes6.2K
Rich Taylor retweeted
Owning a smartphone at 12 was linked to higher eating-disorder symptom risk at 14.
Rich Taylor retweeted
Patients, families, doctors, and nurses are increasingly turning to AI tools, such as Face2Gene, to help identify rare and hard-to-diagnose diseases (@alexljanin / Wall Street Journal)
(Visit Techmeme dot com for the link and full context!)
Rich Taylor retweeted
AI is improving the diagnosis of rare diseases.
gift link
wsj.com/health/ai-is-helping…
An example @MayoClinic, where AI ECGs have been routinely implemented (one of very few health systems)
Rich Taylor retweeted
The traditional drug development model works for millions. But what happens when a patient is the only person in the world with their specific genetic mutation?
The frontier of medicine has shifted toward N-of-1 therapies—hyper-customized treatments designed for a single individual. But to save lives at scale, we must transform these isolated miracles into a repeatable, standardized system.
That is exactly what we are unpacking at the 2026 RARE Drug Development Symposium.
Join us for "Scaling N of 1 - A Collective Effort," a vital fireside chat featuring two pioneers redefining rare disease innovation:
Charlene Son Rigby, CEO of Global Genes
Dr. Tim Yu, Principal Investigator at Boston Children's Hospital
If you are attending the Symposium and are passionate about the future of personalized medicine, add this session to your calendar!
👇 Register today to secure your spot and join the conversation.
globalgenes.org/rdds-2026/
@GlobalGenes
Rich Taylor retweeted
Chromatography-Free Preparation of (4aR,8aR)-2,3-Dimethoxy-2,3-dimethyl-2,3,4a,8a-tetrahydrobenzo[b][1,4]dioxin-6(5H)-one
Submitting Authors: Allie W. Guerra, Coleman D. Walker and Joshua G. Pierce
Checking Authors: Brandon M. Sarrels and Christopher D. Vanderwal
Rich Taylor retweeted
Our guys completed this year’s Lift for Life, raising over $54,000 for rare disease research!
#GoIrish☘️
Rich Taylor retweeted
here is Mamdani's entire speech at the Knicks parade, which is easily the best speech I've ever heard at an event of this sort
Rich Taylor retweeted
Organic Superbase t-Bu-P4 Catalyzed Concerted Nucleophilic Aromatic Substitution
Submitting Authors: Ozora Sasamoto, Biswajit Das, and Masanori Shigeno
Checking Authors: Hayato Machii, Hirofumi Ueda, and Hidetoshi Tokuyama
Rich Taylor retweeted
Copper-Mediated Oxidative Bromodifluoromethylation of Phenols: Preparation of Phenyl 4-(bromodifluoromethoxy) benzoate
Submitting Authors: Wen-Juan Yuan, Chao-Lai Tong, and Feng-Ling Qing
Checking Authors: Uros Vezonik, Sabela Vega-Ces, and Nuno Maulide
Rich Taylor retweeted
Preparation of 2-Iodoxybenzoic Acid (IBX)
Submitting Authors: Marianna C. Tonoyan, Aimee K. Long, and Neil K. Garg
Checking Authors: Milos Vavrik, Nikolaos Skoulikas, and Nuno Maulide
Rich Taylor retweeted
Electrochemical Aromatic C-H DABCOylation: Synthesis of Aryl DABCOnium (Bis)tetrafluoroborate
Submitting Authors: Griffin Stewart and Christian Malapit
Checking Authors: Negin Nabavi and Sophie A. L. Rousseaux
Rich Taylor retweeted
Preparation of 3-(Diphenylphosphino)propanol (ProPhos) and its Use in Nickel-Catalyzed Suzuki-Miyaura Coupling
Submitting Authors: Jin Yang, Rui Zhang, Tianning Diao
Checking Authors: Benjamin S. Y. Chiu and Sophie A. L. Rousseaux
Rich Taylor retweeted
Synthesis of 2-Oxo-2H-Pyran-3-yl Trifluoromethanesulfonate from Mucic Acid
Submitting Authors: Konstantin Günther, Lorenz Erlbacher, Daniel Kaiser, and Nuno Maulide
Checking Authors: Bryce M. Dye and Richard E. Taylor
Rich Taylor retweeted
Rhodium-Catalyzed Atroposelective Azide-Alkyne Cycloaddition
Submitting Authors: Linwei Zeng, Jiaming Li, Sunliang Cui
Checking Authors: Moshood O. Ganiu and Nathan D. Ide
Rich Taylor retweeted
My lab at @Stanford is looking to hire postdocs for multiple projects on cancer biology and therapeutics. Our recent work has uncovered some truly remarkable mechanisms for cytotoxic small molecules and we're looking to build on this research. If interested, see below:
Rich Taylor retweeted
Tomorrow, we launch.
At sunset tonight, Artemis II waits on the pad, ready to carry astronauts potentially farther than any humans have traveled in more than half a century.
The next era of exploration begins.
Rich Taylor retweeted
WELP—As result of all NIH grants requiring RFK Jr and White House approval… we now have 90% less funding for medical research. We are sacrificing our children’s future — all for what???
Rich Taylor retweeted
Trump has collapsed cancer research.
—> The National Cancer Institute hasn’t made a single grant this fiscal year
newyorker.com/magazine/2026/…
Honored to participate in today’s Arthur G. Schultz Memorial Symposium @rpi. I am grateful to have been trained under his mentorship.
Rich Taylor retweeted
Here is the "effective payline" for each institute, estimated (by Claude) as the percentile where one can expect 80% probability of funding from a logistic regression fit. The effective payline has gone from a historic ~12% to 6% in 2025.
NIH FY2025 funding data finally emerges on RePORT drugmonkey.wordpress.com/202… via @drugmonkeyblog
